Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study).

Costa DJ, Marteau P, Amouyal M, Poulsen LK, Hamelmann E, Cazaubiel M, Housez B, Leuillet S, Stavnsbjerg M, Molimard P, Courau S, Bousquet J.

Eur J Clin Nutr. 2014 May;68(5):602-7. doi: 10.1038/ejcn.2014.13. Epub 2014 Feb 26.

PMID:
24569538
2.

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.

Nayak AS, Philip G, Lu S, Malice MP, Reiss TF; Montelukast Fall Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2002 Jun;88(6):592-600.

PMID:
12086367
3.

A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.

Ratner PH, van Bavel JH, Martin BG, Hampel FC Jr, Howland WC 3rd, Rogenes PR, Westlund RE, Bowers BW, Cook CK.

J Fam Pract. 1998 Aug;47(2):118-25.

PMID:
9722799
4.

Evaluation of the effect of Lactobacillus paracasei (HF.A00232) in children (6-13 years old) with perennial allergic rhinitis: a 12-week, double-blind, randomized, placebo-controlled study.

Lin WY, Fu LS, Lin HK, Shen CY, Chen YJ.

Pediatr Neonatol. 2014 Jun;55(3):181-8. doi: 10.1016/j.pedneo.2013.10.001. Epub 2013 Nov 20.

5.
6.

Onset of action of loratadine/montelukast in seasonal allergic rhinitis patients exposed to grass pollen.

Horak F, Zieglmayer P, Zieglmayer R, Lemell P.

Arzneimittelforschung. 2010;60(5):249-55.

PMID:
20533761
7.

Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.

Demoly P, Dreyfus I, Dhivert-Donnadieu H, Mesbah K.

Ann Allergy Asthma Immunol. 2009 Sep;103(3):260-6. doi: 10.1016/S1081-1206(10)60191-3.

PMID:
19788025
9.
10.

Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit.

Day JH, Briscoe MP, Ratz JD, Danzig M, Yao R.

Ann Allergy Asthma Immunol. 2009 Apr;102(4):328-38. doi: 10.1016/S1081-1206(10)60339-0.

PMID:
19441605
11.

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.

Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.

Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9.

PMID:
14756468
12.

Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.

Pradalier A, Neukirch C, Dreyfus I, Devillier P.

Allergy. 2007 Nov;62(11):1331-4. Epub 2007 May 23.

13.

Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis.

Holmberg K, Tonnel AB, Dreyfus I, Olsson P, Cougnard J, Mesbah K, Devillier P.

Allergy. 2009 Nov;64(11):1663-70. doi: 10.1111/j.1398-9995.2009.02096.x. Epub 2009 Sep 9. Erratum in: Allergy. 2010 Mar;65(3):412.

14.

Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.

Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R.

Ann Allergy Asthma Immunol. 2000 Apr;84(4):451-9.

PMID:
10795655
15.
16.

Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.

Ratner P, Falqués M, Chuecos F, Esbrí R, Gispert J, Peris F, Luria X, Rosales MJ.

Int Arch Allergy Immunol. 2005 Dec;138(4):312-8. Epub 2005 Oct 11.

PMID:
16224195
17.

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.

Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.

J Allergy Clin Immunol. 2000 May;105(5):917-22.

PMID:
10808172
18.

Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life.

Condemi J, Schulz R, Lim J.

Ann Allergy Asthma Immunol. 2000 May;84(5):533-8.

PMID:
10831008

Supplemental Content

Support Center